SEC Form D private-offering filing

Biolexis Therapeutics Inc.

Name: Biolexis Therapeutics Inc. - new SEC Form D private-offering filing, Lehi, UT
Published: 2026-06-03

A new SEC Form D private-offering notice from Lehi, UT, a $12,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Biolexis Therapeutics Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing oral small molecule GLP-1 and AMPK therapies for metabolic and muscle wasting diseases.

Filed 2026-06-03Filed to raise $12,000,000First money in 2026-05-20Raised so far $1,600,000HQ (as filed) Lehi, UTSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified biolexistx.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Utah →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.